These outcomes, along with a preceding report showing that a small-molecule ACKR3 agonist CCX771 reveals anxiolytic-like habits in mice,two assist the strategy of focusing on ACKR3 as a singular method to modulate the opioid program, which could open new therapeutic avenues for opioid-similar Is